The effectiveness of specific immunotherapy of allergic diseases of respiratory organs from the standpoint of evidence-based medicine. The results of a 5-year retrospective study

Zabolotnyĭ D.I.; Gogunskaia I.V.; Zabolotnaia D.D.; Zaritskaia I.S.

doi:https://doi.org/

Zabolotnyĭ D.I.

Institut otolaringologii im. prof. A.S. Kolomiĭchenko NAMN Ukrainy, Kiev

Gogunskaia I.V.

Institut otolaringologii im. prof. A.I. Kolomiĭchenko NAMN Ukrainy, Kiev

Zabolotnaia D.D.

Institut otolaringologii im. prof. A.I. Kolomiĭchenko NAMN Ukrainy, Kiev

Zaritskaia I.S.

Institut otolaringologii im. prof. A.I. Kolomiĭchenko NAMN Ukrainy, Kiev

The effectiveness of specific immunotherapy of allergic diseases of respiratory organs from the standpoint of evidence-based medicine. The results of a 5-year retrospective study

Authors:

Zabolotnyĭ D.I., Gogunskaia I.V., Zabolotnaia D.D., Zaritskaia I.S.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2013;78(5): 18‑21

Read: 1095 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Zabolotnyĭ DI, Gogunskaia IV, Zabolotnaia DD, Zaritskaia IS. The effectiveness of specific immunotherapy of allergic diseases of respiratory organs from the standpoint of evidence-based medicine. The results of a 5-year retrospective study. Russian Bulletin of Otorhinolaryngology. 2013;78(5):18‑21. (In Russ.)

Подписка 2026 Вестник оториноларингологии (Russian Bulletin of Otorhinolaryngology)

Использование инфографики авторами научных работ

Close metadata

Abstract:

The objective of this first Ukrainian 5-year retrospective study was to subjectively evaluate the effectiveness of specific immunotherapy (sublingual and injection) of the upper respiratory tract in the patients presenting with seasonal allergic rhinitis (SAR), perennial allergic rhinitis (PAR), SAR and PAR with polyvalent sensitization. The analysis of the results of sublingual, injection, and combined specific immunotherapy given to 750 patients allowed to describe them as "excellent" and "good" in the groups with PAR (83% of the total number), SAR (93%), SAR and PAR with polyvalent sensitization (84%).

Keywords:

seasonal allergic rhinitis

perennial allergic rhinitis

allergic rhinitis with polyvalent sensitization

specific immunotherapy

Authors:

Zabolotnyĭ D.I.

Institut otolaringologii im. prof. A.S. Kolomiĭchenko NAMN Ukrainy, Kiev

Gogunskaia I.V.

Institut otolaringologii im. prof. A.I. Kolomiĭchenko NAMN Ukrainy, Kiev

Zabolotnaia D.D.

Institut otolaringologii im. prof. A.I. Kolomiĭchenko NAMN Ukrainy, Kiev

Zaritskaia I.S.

Institut otolaringologii im. prof. A.I. Kolomiĭchenko NAMN Ukrainy, Kiev

Close metadata

References:

Bousquet J., Khaltaev N., Cruz A.A., Denburg J. World Health Organization. Allergic rhinitis and its impact on asthma. Allergy 2008; 63: Suppl 86: 8-160.
Jacobsen L. Preventive aspects of specific immunotherapy. Current Allergy & Clinical Immunology 2003; 16: 3: 102-104.
Passalacqua G., Canonica G.W. Allergen-specific sublingual immunotherapy for respiratory allergy. BioDrugs 2001; 15: 8: 509-519.
Saltoun C.A. Update of efficacy of allergen immunotherapy for allergic rhinitis and asthma. Allergy Asthma Proc 2002; 23: 6: 377-380.
Zak-Nejmark I., Nowak A., Malolepszy J. Allergen immunotherapy decreases specific allergen-induced expression of Fas and FasL on CD4+ and CD8+ cells T. J Invest Allergol Clin Immunol 2005; 15: 1: 63-68.
Varney V.A., Tabbah K., Mavroleon G., Frew A.J. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial. Clin Exp Allergy 2003; 33: 8: 1076-1082.
Timothy A., James R. Banks Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. J Allergy Clin Immunol 2006; 117: 263-268.
Grembiale R.D., Camporota L., Naty S., Tranfa C.M. Effects of specific immunotherapy in allergic rhinitis individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000; 162: 6: 2048-2052.
Sanchez Palacios A., Schamann F. Sublingual immunotherapy with cat epithelium extract. Personal experience. Allergol Immunopathol 2001; 29: 2: 60-65.
Dinakar C., Portnoy J.M. Allergen immunotherapy in prevention of asthma. Curr Opin Allergy Clin Immunol 2004; 4: 2: 131-136.
Stacie M. Jones. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the pat-study). Pediatrics 2003; 112: 2: 464-465.
Möller C., Dreborg S., Ferdousi H.A., Halken S., Høst A., Jacobsen L., Koivikko A., Koller D.Y., Niggemann B., Norberg L.A., Urbanek R., Valovirta E., Wahn U. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002; 109: 2: 251-256.
Eng P.A., Reinhold M., Gnehm H.P. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 2002; 57: 306-312.
Purello-D'Ambrosio F., Gangemi S., Merendino R.A., Isola S., Puccinelli P., Parmiani S., Ricciardi L. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001; 31: 8: 1295-1302.
Pukhlik B.M., Goguns'ka І.V., Korits'ka І.V., Yakovenko O.K. Efektivnіst' spetsifіchnoї іmunoterapії pri alergіchnikh zakhvoryuvannyakh organіv dikhannya z pozitsії dokazovoї meditsini. Povіdomlennya 1. Zhurn vushn, nos і gorl khvorob 2009; 6: 29-38.